Treatment of Thyroiditis
Treatment of thyroiditis depends on the specific type and phase of disease, but most commonly involves symptomatic management with beta-blockers during hyperthyroid phases, levothyroxine replacement for hypothyroidism, and NSAIDs or corticosteroids for painful inflammatory forms.
Treatment Approach by Thyroiditis Type
Hashimoto's (Lymphocytic) Thyroiditis
Levothyroxine replacement is the cornerstone of treatment for patients with overt hypothyroidism or symptomatic disease. 1
Initiate levothyroxine for:
Dosing strategy:
Long-term management:
Subacute (DeQuervain's) Thyroiditis
Treatment focuses on symptomatic relief of pain and managing the triphasic thyroid dysfunction pattern. 2, 3
For thyroid pain:
For hyperthyroid phase:
For hypothyroid phase:
Prognosis:
Postpartum Thyroiditis
Management is similar to subacute thyroiditis but without the pain component. 6
Hyperthyroid phase:
Hypothyroid phase:
Monitoring:
Drug-Induced Thyroiditis (Immune Checkpoint Inhibitors)
Continue immunotherapy in most cases while managing thyroid dysfunction. 6
For hypothyroidism:
For hyperthyroidism:
Monitoring:
Common Pitfalls to Avoid
- Do not use antithyroid drugs for destructive thyroiditis (subacute, postpartum) as hyperthyroidism results from hormone release, not overproduction 2
- Do not delay corticosteroid treatment in severe subacute thyroiditis waiting for symptom resolution with NSAIDs alone 4, 5
- Do not assume all thyroiditis is permanent—many forms are self-limited and require surveillance rather than lifelong treatment 2, 4
- Do not start high-dose levothyroxine in elderly patients or those with cardiac disease; start low and titrate slowly 1
- Do not use radioactive iodine during pregnancy or breastfeeding (contraindicated for 4 months posttreatment) 6
Follow-Up and Surveillance
- All forms of thyroiditis require ongoing monitoring for changes in thyroid function 2
- Consider endocrinology consultation for unusual presentations, difficulty titrating therapy, or concern for central hypothyroidism 1
- Monitor for progression from subclinical to overt hypothyroidism, particularly in Hashimoto's thyroiditis 1